adamantane has been researched along with Myocardial Ischemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel Ghafar, MT; Atlam, R; Elsaadany, A; Eshra, KA; Rizk, FH; Shaaban, AE; Shalaby, MM; Soliman, NA | 1 |
Chattipakorn, N; Chattipakorn, S; Chinda, K; Sanit, J | 1 |
Apaijai, N; Chattipakorn, N; Chattipakorn, S; Chinda, K; Palee, S | 1 |
Apaijai, N; Chattipakorn, N; Chattipakorn, SC | 1 |
1 trial(s) available for adamantane and Myocardial Ischemia
Article | Year |
---|---|
Vildagliptin Recruits Regulatory T Cells in Patients Undergoing Primary Percutaneous Coronary Intervention.
Topics: Adamantane; C-Reactive Protein; CD4 Lymphocyte Count; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Interferon-gamma; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Nitric Oxide; Nitriles; Percutaneous Coronary Intervention; Peroxidase; Pyrrolidines; Serum Albumin; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1; Vildagliptin | 2018 |
3 other study(ies) available for adamantane and Myocardial Ischemia
Article | Year |
---|---|
Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart.
Topics: Adamantane; Animals; Apoptosis; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Male; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitriles; Pyrrolidines; Rats; Rats, Wistar; Vildagliptin | 2014 |
Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats.
Topics: Adamantane; Animals; Arrhythmias, Cardiac; Calcium; Cardiotonic Agents; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Heart Rate; Insulin Resistance; Intracellular Space; Male; Metformin; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitriles; Obesity; Pyrrolidines; Rats; Rats, Wistar; Ventricular Dysfunction, Left; Vildagliptin | 2014 |
Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control.
Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Insulin Resistance; Myocardial Ischemia; Nitriles; Obesity; Oxidative Stress; Pyrrolidines; Rats; Sitagliptin Phosphate; Ventricular Function, Left; Vildagliptin | 2016 |